Research team led by Dr. Linda Wastila aims to understand how a nationwide effort to reduce the use of antipsychotic medications in long-term care facilities has impacted those facilities’ use of other medications and patient health outcomes.

New company established by School of Pharmacy faculty members releases its first software platform designed to assist strategic decision making across the fields of drug development and individualized patient care.

Event sponsored by the University of Maryland Center of Excellence in Regulatory Science and Innovation addressed current knowledge gaps in the dissolution similarity evaluation of pharmaceutical products.

The Dennis W. Jahnigen Memorial Award, presented by the American Geriatrics Society, recognizes individuals who have helped advance geriatrics education across the health professions.

Dr. Magaly Rodriguez de Bittner recognized for her dedication to fostering interdisciplinary team programs, projects, and models that focus on the improvement of health care.

International award recognizes outstanding achievements at the forefront of research or leadership in the field of pharmacometrics.

Pharmacists in the School’s e-Health Center will leverage state-of-the-art telehealth technologies to provide in-home, comprehensive medication reviews to patients.

Grant from the Maryland Health Care Commission leverages cutting-edge telehealth technologies to improve health outcomes for patients with chronic obstructive pulmonary disease.

Researchers from the School of Pharmacy and Johns Hopkins University use PET scans and pharmacometric modeling to help inform dosing recommendations for first-line tuberculosis drug.

National award is presented each year to an individual who has made significant contributions to the field of consultant and senior care pharmacy.

Grant from the U.S. Food and Drug Administration will span three years and include evaluations for more than 200 nominated substances.

Latest renewal allows for up to $5 million per year over five years, and will help M-CERSI further advance its mission to promote the development of new tools, standards, and approaches to assess the safety, efficacy, quality, and performance of FDA-regulated products.